Fukashi Yamamichi1, Katsumi Shigemura2, Koichi Kitagawa3, Kei Takaba4, Issei Tokimatsu5, Soichi Arakawa6, Masato Fujisawa1. 1. Division of Urology, Department of Organ Therapeutics, Kobe University Graduate School of Medicine, Kobe, Japan. 2. Division of Urology, Department of Organ Therapeutics, Kobe University Graduate School of Medicine, Kobe, Japan; Department of International Health Sciences, Kobe, Japan; Infecion Control and Prevention, Kobe University Hospital, Kobe, Japan. 3. Division of Translational Research for Biologics, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan. 4. Infecion Control and Prevention, Mie Prefectural General Medical Centre, Yokkaichi, Japan. 5. Infecion Control and Prevention, Kobe University Hospital, Kobe, Japan. 6. Division of Urology, Department of Organ Therapeutics, Kobe University Graduate School of Medicine, Kobe, Japan; Infecion Control and Prevention, Kobe University Hospital, Kobe, Japan.
Abstract
INTRODUCTION: Urosepsis is a severe infection that can cause shock afterwards. The purpose of this study is to investigate the clinical and bacterial risk factors for shock in those cases with urosepsis caused by urinary tract infection in a multicentre study. METHODS: Our study included 77 consecutive urosepsis cases from four hospitals. We examined factors such as patient characteristics, underlying disease, serum white blood cell (WBC) count, platelet count, C-reactive protein (CRP) level at the time of diagnosis of urosepsis, urinary tract occlusion, causative bacteria, and bacterial antibiotic susceptibilities. Statistical analyses were performed to assess the potential risk factors for shock during the clinical course of urosepsis by a multivariate analysis. RESULTS: We had 38 male and 39 female patients aged 25-104 (median 73). Underlying diseases included cancers (n=22, 28.6 %) and diabetes mellitus (n=17, 22.1 %). Positive blood culture was seen in 74 cases; these involved 88 bacterial strains, of which Escherichia coli was the most common (34 strains, 38.6 %). There were 31 cases with shock (40.3 %) and multivariate analyses demonstrated that serum CRP was the only clinical risk factor for shock due to urosepsis. CONCLUSIONS: Our study demonstrated that serum CRP was a risk factor for shock during urosepsis in a multicentre analysis. Further prospective studies with a greater number of patients are needed to draw more definitive conclusions.
INTRODUCTION: Urosepsis is a severe infection that can cause shock afterwards. The purpose of this study is to investigate the clinical and bacterial risk factors for shock in those cases with urosepsis caused by urinary tract infection in a multicentre study. METHODS: Our study included 77 consecutive urosepsis cases from four hospitals. We examined factors such as patient characteristics, underlying disease, serum white blood cell (WBC) count, platelet count, C-reactive protein (CRP) level at the time of diagnosis of urosepsis, urinary tract occlusion, causative bacteria, and bacterial antibiotic susceptibilities. Statistical analyses were performed to assess the potential risk factors for shock during the clinical course of urosepsis by a multivariate analysis. RESULTS: We had 38 male and 39 female patients aged 25-104 (median 73). Underlying diseases included cancers (n=22, 28.6 %) and diabetes mellitus (n=17, 22.1 %). Positive blood culture was seen in 74 cases; these involved 88 bacterial strains, of which Escherichia coli was the most common (34 strains, 38.6 %). There were 31 cases with shock (40.3 %) and multivariate analyses demonstrated that serum CRP was the only clinical risk factor for shock due to urosepsis. CONCLUSIONS: Our study demonstrated that serum CRP was a risk factor for shock during urosepsis in a multicentre analysis. Further prospective studies with a greater number of patients are needed to draw more definitive conclusions.
Authors: Florian M E Wagenlehner; Christoph Lichtenstern; Caroline Rolfes; Konstantin Mayer; Florian Uhle; Wolfgang Weidner; Markus A Weigand Journal: Int J Urol Date: 2013-05-29 Impact factor: 3.369
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Intensive Care Med Date: 2003-03-28 Impact factor: 17.440
Authors: Cees van Nieuwkoop; Tobias N Bonten; Jan W van't Wout; Ed J Kuijper; Geert H Groeneveld; Martin J Becker; Ted Koster; G Hanke Wattel-Louis; Nathalie M Delfos; Hans C Ablij; Eliane M S Leyten; Jaap T van Dissel Journal: Crit Care Date: 2010-11-17 Impact factor: 9.097
Authors: Henry E Wang; Nathan I Shapiro; Monika M Safford; Russell Griffin; Suzanne Judd; Joel B Rodgers; David G Warnock; Mary Cushman; George Howard Journal: PLoS One Date: 2013-07-23 Impact factor: 3.240
Authors: Zafer Tandoğdu; Ricardo Bartoletti; Tomasso Cai; Mete Çek; Magnus Grabe; Ekaterina Kulchavenya; Bela Köves; Vandana Menon; Kurt Naber; Tamara Perepanova; Peter Tenke; Björn Wullt; Truls Erik Bjerklund Johansen; Florian Wagenlehner Journal: World J Urol Date: 2015-12-11 Impact factor: 4.226